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ABSTRACT 
Aim: It can be difficult for adolescents with inflammatory bowel disease (IBD) to make the transition 
from paediatric to adult care. We studied the outcomes of this process and defined what constituted 
a successful transition.  
Methods: In 2008, 50 adolescents who attended our IBD transition clinic completed IBD-yourself, a 
self-efficacy questionnaire that we had previously developed and validated. We approached the 
subjects in 2014, two to six years after they transferred to adult care, and 35 agreed to take part in 
the current study. The outcome of transition was assessed by our newly developed Transition 
Yourself Score. In addition, the relationship between self-efficacy and the outcome of the transition 
was measured.  
Results: The mean age of the patients was 21.8 years and 69% suffered from Crohn’s disease. The 
transition process was successful in 63% of cases, moderately successful in 31% and failed in 6%. A 
successful transition was associated with effective use of medication and clinical remission at the 
time of transfer, but could not be predicted by self-efficacy.  The Transition Yourself Score will be 
validated in future studies. 
Conclusion: Nearly two-thirds (63%) of the adolescents who attended the IBD transition clinic had a 
successful transition to adult care.  
 
 
KEY NOTES 
 The definition of a successful transition from paediatric to adult care for patients with  
inflammatory bowel disease (IBD) is currently unknown. 
 Using our Transition Yourself Score, which measures the outcome of transition, we found 
that 63% of the 35 patients who attended our IBD transition clinic had a successful 
transition. 
 Self-efficacy did not seem to predict a successful transition, but clinical remission at transfer 
might.  
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INTRODUCTION  
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder of the intestine and 
manifests in adolescence in about 25% of cases (1, 2). As IBD is a lifelong disease, all paediatric 
patients will need to undergo the transfer to adult care. It is advisable to have a transition period to 
prepare patients and parents for the transfer, which refers to the actual handover of the patient to 
adult healthcare (3). A failed transition can adversely affect IBD related outcomes. It can increase 
non-adherence, non-attendance, hospitalisation rates and the need for surgery (4, 5). During the 
transition process, patients, their parents and the paediatric and adult gastroenterologist have 
specific tasks. Patients should acquire disease knowledge, autonomy and self-management (6, 7), 
while parents need to stimulate their child’s independence and physicians should be knowledgeable 
about adolescents’ developmental and health issues and prepare them for transfer (3). Transition 
programmes are designed to facilitate the transition process and increase knowledge and self-
management (3, 8). Self-efficacy, a person’s belief in their capability to organise and execute the 
actions required to deal with prospective situations, is thought to be a prerequisite for self-
management (9, 10). It reflects self-care responsibility and has been shown to be a predictor of 
readiness to transfer (11). We previously developed and validated IBD-yourself, a specific IBD 
knowledge and self-efficacy questionnaire (12).  
The optimal model for IBD transitional care is currently unknown, as is the definition of a 
successful transition, due to the scarcity of outcome research. We aimed to develop a tool, the 
Transition Yourself Score, to measure the success of transition. The Transition Yourself Score was 
applied to our IBD transition cohort to assess transition outcomes one year after transfer. In 
addition, we assessed the predictive value of self-efficacy for successful transition. 
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METHODS 
Participants 
In 2008, 50 patients from our IBD transition clinic participated in the validation study of the self-
efficacy questionnaire, IBD-yourself (12). Of these, 35 gave informed consent to participate in the 
current study in 2014. Data on patient characteristics, disease type, treatment and outpatient clinic 
visits after transfer were retrieved from their medical records. The study was approved by the 
Medical Ethics Committee of the Erasmus Medical Centre, Rotterdam, The Netherlands.  
 
IBD transition clinic 
Adolescents aged 16 to 18 years old with IBD are seen at the outpatient clinic, which is located in the 
adult gastroenterology department. A multidisciplinary team, consisting of a paediatric 
gastroenterologist, a paediatric IBD nurse specialist, an adult gastroenterologist and a family 
therapist, discuss all patients before the start of the clinic. Patients visit the clinic at least four times 
a year, where they are seen by either the paediatric gastroenterologist or the paediatric IBD nurse 
specialist. Once a year the adolescent patients also meet the adult gastroenterologist, to get 
acquainted with the adult healthcare system. During clinic visits, both the nurse and doctors check 
for disease knowledge, self-efficacy and self-management skills. Around the age of 18, patients are 
transferred, either within our centre or to a hospital closer to home. The choice of the adult care 
team depends primarily on the complexity of the disease and secondarily on the patient’s 
preference and where they live. As part of the routine care for all patients, irrespective of their 
disease severity, an appointment at the gastroenterology department is made within three to six 
months after transfer. At this time an extensive transfer letter, including the patient’s medical 
history, is sent to the adult medical healthcare provider, with a copy to the patient. 
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Measurements 
Transition Yourself Score  
A score reflecting the outcome of the transition process was developed based on previous literature 
(13) and the outcome of a focus group meeting with IBD experts. The Transition Yourself Score was 
applied to participants one year after their transfer to adult care. The following items were rated: 
adherence to visits at the gastroenterology outpatient clinic, adherence to medication and 
qualitative evaluation of transition by the patient. A pre-test of the score with a representative 
group of 10 patients resulted in minor adjustments in the language. 
We scored the adherence to the visits to the adult gastroenterologist by determining when the 
patients first appeared in the gastroenterology outpatient clinic. The percentage of missed 
scheduled outpatient visits within the first year was calculated by dividing the number of missed 
visits by the number of planned visits times 100. Rescheduled visits were not counted as non-
attendance. Adherence to medication was determined by an adherence interview (Table S1) (14). 
The interview contained 10 questions regarding medication use, missed medication and the 
experienced burden of the medication regimen. Patients could receive one point per question, with 
a maximum score of 10. Prescriptions for supplements, such as calcium or iron, were not included in 
the assessment of medication adherence. Low adherence was indicated by a score below six, 
medium by a score of six to eight and high by a score of eight or more. At enrolment, patients 
retrospectively graded the transition process on a 10-point scale, where one was very poor and 10 
was excellent and these scores are recorded in Table 1. A total score below five indicated a failed 
transition, five or six was moderately successful and above six was successful. For the analysis we 
combined failed and moderately successful transition into the unsuccessful transition category, to 
reflect that improvements were needed in this group. We then compared those findings with the 
group of subjects who had a successful transition. 
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IBD-yourself 
IBD-yourself is questionnaire that was previously developed and validated by our research group to 
explore knowledge about IBD and self-efficacy (12). It covers a number of domains, such as 
knowledge of IBD, diagnostic tests and medication use. Higher scores indicated higher overall levels 
of self-efficacy. As the number of questions could differ between patients, we just provided scores 
for each domain and no total score (Table S2) (12).  
 
Clinical outcome one year after transfer 
Data regarding relapses, disease related complications, admissions, surgery and pregnancies were 
retrieved from medical charts. Clinical relapse was defined as a relapse with a change in treatment 
strategy and, or, hospital admission. 
 
 
Statistical analysis 
Statistical analyses were completed using SPSS 18.0 for Windows (SPSS Inc, Chicago, USA). 
Significance was set at p<0.05. Descriptive statistics were calculated as percentages for discrete data 
and medians with interquartile ranges (IQR) for continuous data. The chi-square test or Fisher’s 
exact test was used to analyse categorical data. Correlation between the IBD-yourself and transition 
success was examined using Spearman’s correlation coefficient and the Mann-Whitney U test. 
 
 
RESULTS 
Patients’ characteristics 
There were 35 adult patients who gave their informed consent, with a median age of 21.9 years and 
interquartile range (IQR) of 21.1-22.6. Of the 50 patients who took part in the 2008 study, two 
declined participation, one patient had died from a metastasised rectal adenocarcinoma due to 
Hermansky Pudlak syndrome and 12 patients had been lost to follow up. The clinical and 
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demographic characteristics are shown in Table 2, in the column total. The baseline characteristics of 
the 35 participants and 15 non-participants did not differ (data not shown), except for educational 
status. Of the non-participants, 80% had low educational status compared to 46% of the 
participants.  
 
Outcome of transition at one year after transfer 
Almost 90% of the patients visited the adult outpatient clinic in the first three to six months after 
transfer. In addition, 85% of the patients missed less than 10% of their outpatient visits in the first 
year after transfer. Most patients had medium medication adherence. Almost 70% of patients 
valued the quality of their transition as good, scoring it above a seven. When we used the total 
Transition Yourself Score, the transition was successful in 22/35 (63%) patients, moderately 
successful in 11 (31%) and failed in two patients (6%) (Table 1). A female patient with Crohn’s 
disease failed the transition as she did not adhere to her medication, did not appear for her first 
appointment and presented more than one year after transfer in the emergency department with a 
clinical relapse. The other patient was a male patient with Crohn’s disease who was transferred to a 
community hospital, but was lost to follow up after transfer.  
 
 
Factors influencing outcome of transition 
The clinical and demographic characteristics did not differ significantly between the group with 
successful and unsuccessful transition (Table 2). In the group with unsuccessful transition. 80% had 
active disease before their transfer to adult care and this approached significance (p=0.052). Female 
patients were more likely than males to have an unsuccessful transfer (p=0.069) (data not shown). 
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Relation between adolescent self-efficacy and successful transition  
Spearman’s correlation showed a significant correlation for the outcome of transition and the IBD-
yourself domain that covered actual behaviour in medication use (r=0.397, p=0.025, n= 35). In 
parallel, adolescents with a successful transition had significantly higher scores in the domain of 
actual behaviour in medication use (Mann Whitney U test: U=60.0, z=-2.208, p=0.027). As shown in 
Table 3, the scores of each IBD-yourself domain were divided in three groups, namely low, medium 
and high. A non-significant trend was seen in seven of the domains, with more patients having a high 
score in the successful transition group. 
 
 
Clinical outcome at one year after transfer 
Of the 35 patients, 10 patients (29%) had a relapse with clinical consequences in the first year after 
transfer. In 50% of these patients, the outcome of their transition was scored as either moderately 
successful or unsuccessful. In contrast, the transition was unsuccessful in 30% of patients without 
relapsing disease. No significant differences were found between the patients with or without 
relapse with respect to the outcome of their transition, therapy adherence and missed outpatient 
clinic visits (data not shown). Of the 35 patients, two underwent surgery, namely resection of the 
remaining colon after hemi-colectomy and resection of perianal skintags, one Crohn’s disease 
patient developed a perianal fistula and received antibiotics and two patients developed a new extra 
intestinal manifestation (arthralgia). One patient became pregnant during anti-tumour necrosis 
factor treatment and delivered a healthy baby. None of the patients developed a malignancy during 
the study period.  
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DISCUSSION 
Our study showed that in our IBD transition clinic, transition was successful in 63% of patients and 
moderately successful in 31% of patients. This modest success ratio indicates ithat there is room for 
improvement in our IBD transition strategy, both in general and in individual patients.  
 
To our knowledge, only one previous study has described the outcome of transition in IBD 
care (15). Non-adherence rates were in accordance with our cohort, but higher rates of 
hospitalisation and disease complications were found after transfer. However, it is not clear at what 
point in the transition process this was assessed. 
 
The outcome of transition has also been described in paediatric patients with other chronic 
diseases with success varying from 42-53% of patients (16-19). All these studies used a restricted 
definition of success, namely attending the first one or two visits in adult care. In our clinic the 
transition process starts early, at the age of 16, with early involvement of the adult 
gastroenterologist. This could explain the relatively higher rates of successful transition in our cohort 
compared to the cohorts of patients with other chronic diseases. 
 
A scoring system for the outcome of transition in IBD is currently not available and we 
decided to develop such an instrument, the Transition Yourself Score. In 2015, a ranking list with key 
elements and indicators of successful transition in general was published (13). This list, together with 
previous literature, supports the elements of the Transition Yourself Score (13, 19-21). A qualitative 
evaluation by the patient was included because patient experiences are of essential importance, 
reflect continuity of care and should be taken into account (13). 
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We hypothesised that patient or disease related factors can influence the outcome of 
transition as well as the actual transition clinic. Our study indicated that female patients and patients 
with an active disease before transfer might be at risk for unsuccessful transition.  
 
Unsuccessful transition may have serious consequences, such as non-adherence, 
hospitalisation or surgery. To our knowledge, there have not been any studies that have measured 
successful transition and correlated these to the clinical outcomes after transfer. Unfortunately, 
because of the limited size of our study, we were not able to do that either.   
 As discussed earlier, it has been suggested that self-efficacy is a prerequisite for self-
management and transfer readiness (10, 11). Whitfield et al investigated self-efficacy in adolescent 
IBD patients and found that mean self-efficacy scores were higher in older patients, but not in 
patients with longer disease duration. Remarkably, communication with the doctor did not improve 
with age and about 80% of patients above 18 years of age reported that they were not independent 
when it came to disease management tasks (22). Unfortunately, this study did not assess if patients 
actually used the skills they claimed to possess. It could be that self-efficacy does not always 
correlate with actual behaviour. Our study showed that actual behaviour could be associated with 
transition success. Since the publication of the IBD-yourself, another self-efficacy scale for 
adolescents and young adults has been developed and validated, but studies using this scale have 
not yet been published (23).      
 
This study had several limitations: the recruitment from a single centre, the retrospective 
nature and the small sample size limited the statistical analysis and generalisability. In addition, 
recall bias could have influenced the patients’ recollections of the item quality of the transition 
process, since some patients participated several years after their transfer. Moreover, 
socioeconomic status was higher in participants than non-participants, which could have influenced 
the results of our study. Furthermore, the Transition Yourself Score needs to be validated and IBD-
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yourself needs to be compared to other measures of self-efficacy for further validation. Lastly, the 
generalisability may be limited because of country specific transition approaches, but the general 
elements chosen to classify the success of transition can be tailored to each local situation.  
 
CONCLUSION 
Despite these limitations, this study was the first to evaluate the outcome of transition in 
IBD by using a new score, the Transition Yourself Score. We showed that, after attending our IBD 
transition clinic, 63% of patients had a successful transition. The IBD-yourself, which measured self-
efficacy, did not predict a successful transition, which can question the importance of self-efficacy. 
We stress the importance of not only assessing self-efficacy or self-management, but also the 
outcome of transition and clinical disease course after transfer. If predictors for a successful 
transition can be identified, then transition programmes can be optimised. The Transition Yourself 
Score is a simple tool to assess the efficacy of transition programmes, but it needs to be validated.  
 
Abbreviations: IBD: Inflammatory bowel disease, IQR: interquartile ranges  
Finance: This study did not receive any specific funding 
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Table 1. Transition Yourself Score   
Items Score Frequency (n=35), n 
(%) 
Time to first outpatient visit to adult gastroenterologist  
Unknown or after 12 months 0  1 (2.9) 
After 6-12 months 1  3 (8.6) 
Within 3-6 months 2  31 (88.6) 
Non-attendance rates at outpatient clinic < 12 months after transfer 
>25% 0  2 (5.7) 
10-25% 1  3 (8.6) 
None / <10%  2  30 (85.7) 
Medication adherence   
Low adherence 0  4 (11.4) 
Medium adherence 1  17 (48.6) 
High adherence  2  5 (14.3) 
No medication prescribedA  9 (25.7) 
Quality of transition (grade 0-10) B  
< 5.5 0  0 
5.5-7 1  11 (31.4) 
>7 2 24 (68.6) 
Total score: 
Failed transition  
 
<4 
  
2 (5.7) 
Moderate successful transition 5 or 6  11 (31.4) 
Successful transition >6 22 (62.9) 
 
A 
These patients were given two points in total transition score. 
B 
as experienced by the transferred patient 
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Table 2. Patient characteristics 
 
 Total  
(n=35) 
Unsuccessful  
transition¥ (n=13) 
Successful 
transition 
(n=22) 
p value§  
 
Age at diagnosis (years), (median, IQR) 13 (12-15) 14 (11.5-15.0) 13 (12.0-15.0) 0.875 
Months in transition clinic before transfer (median, IQR) 13 (5-18) 10 (5.0-18.0) 13 (4.8-17.8) 0.811 
Disease duration at transfer (median, IQR) 7 (7-10) 4.1 (3.0-6.9) 4.5 (2.9-6.1) 0.864 
Years after transfer at inclusion in study 
<2  
2-4  
4-6  
 
2 (5.7%) 
20 (57.1%) 
13 (37.1%) 
 
1 (7.7%) 
7 (53.8%) 
5 (38.5%) 
 
1 (4.5%) 
13 (59.1%) 
8 (36.4%) 
1.0 
Gender (male), no (%) 15 (42.9%) 3 (23.1%) 12 (54.5%) 0.070 
Disease type, CD, no (%) 24 (68.6%) 9 (69.2%) 15 (68.2%) 1.0 
Medication at transfer‡ 
Aminosalicylates 
Immunomodulators 
Anti-TNF  
Prednisone  
No medication 
 
9 (25.7%) 
25 (71.4%) 
12 (34.2%) 
2 (5.7%) 
1 (2.9%) 
 
3 (23.1%) 
9 (69.2%) 
5 (38.5%) 
1 (7.7%) 
0 
 
6 (27.2%) 
16 (72.7%) 
7 (31.8%) 
1 (4.5%) 
1 (4.5%) 
0.840 
Active disease during transfer 5 (14.3%) 4 (30.8%) 1 (4.5%) 0.052 
Relapse within first year after transfer 10 (28.6%) 5 (38.5%) 5 (22.7%) 0.444 
Educational level 
Low 
Medium 
High 
 
16 (45.7%) 
13 (37.2%) 
6 (17.1%) 
 
7 (53.8 %) 
3 (23.1%) 
3 (23.1%) 
 
9 (40.1%) 
10 (45.5%) 
3 (13.6%) 
0.467 
 
‡ Some patients were prescribed more than one kind of medication ¥ moderately successful and failed transition § successful versus 
unsuccessful transition  
Note: percentages are displayed as column percentages  
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Table 3. IBD- yourself and outcome of transition 
Domains IBD Yourself Unsuccessful 
transition 
(failed&moderate) 
(n=13), n (%) 
Successful 
transition  
 
(n=22), n (%) 
Self-efficacy in knowledge of IBD (n=35) 
12-14 points 
15-17 points 
18-20 points 
 
2 (15.4%) 
6 (46.2%) 
5 (38.5%) 
 
1 (4.5%) 
12 (54.5%) 
9 (40.9%) 
Self-efficacy in knowledge of diagnostic tests (n=35) 
14-17 points 
18-21 points 
22-24 points 
 
2 (15.4%) 
7 (53.5%) 
4 (30.8%) 
 
4 (18.2%) 
8 (36.4%) 
10 (45.5%)  
Self-efficacy in knowledge of medication (n=27) 
17-22 points 
23-27 points 
28-32 points 
 
4 (40.0%) 
4 (40.0%) 
2 (20.0%) 
 
4 (23.5%) 
6 (35.3%) 
7 (41.2%) 
Actual behaviour medication use (n=32)* 
7-10 points 
11-14 points 
15-17 points 
 
1 (10.0%) 
7 (70.0%) 
2 (20.0%) 
 
2 (9.1%) 
3 (13.6%) 
17 (77.3%) 
Self-efficacy in skills for independent outpatient clinic visits (n=35) 
12-20 points 
21-28 points 
     29-36 points 
 
2 (15.4%) 
5 (38.5%) 
6 (46.2%) 
 
3 (13.6%) 
9 (40.9%) 
10 (45.5%)  
Actual behaviour outpatient clinic (n=26) 
4-6 points 
7-8 points 
 
10 (90.9%) 
1 (9.1%) 
 
9 (60.0%) 
6 (40.0%) 
Self-efficacy in coping with IBD (n=34) 
5-8 points 
9-12 points 
13-16 points 
 
1(8.3%) 
4 (33.3%) 
7 (58.3%) 
 
1 (4.5%) 
6 (27.3%) 
15 (68.2%) 
Self-efficacy in knowledge of transition process (n=31) 
32-42 points 
43-52 points 
53-62 points 
 
3 (25.0%) 
4 (33.3%) 
5 (41.7%) 
 
2 (10.5%) 
8 (42.1%) 
9 (47.4%) 
Self-efficacy in transfer readiness (n=34) 
4-6 points 
7-8 points 
 
10 (76.9%) 
3 (23.1%) 
 
14 (66.7%) 
7 (33.3%) 
 
*p<0.05  
 
 
